ABI-007 (Abraxane)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABI-007 (Abraxane), covering 2012-03-13 to 2012-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer [Phase 2]